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PI3KOval cells constitute an interesting hepatic cell population. They contribute to sustain liver regeneration during
chronic liver damage, but in doing this they can be target of malignant conversion and become tumor-initiating
cells and drive hepatocarcinogenesis. The molecular mechanisms beneath either their pro-regenerative or
pro-tumorigenic potential are still poorly understood. In this study, we have investigated the role of the HGF/c-
Met pathway in regulation of oval cell migratory and invasive properties. Our results show that HGF induces
c-Met-dependent oval cell migration both in normal culture conditions and after in vitro wounding.
HGF-triggered migration involves F-actin cytoskeleton reorganization, which is also evidenced by activation of
Rac1. Furthermore, HGF causes ZO-1 translocation from cell–cell contact sites to cytoplasm and its concomitant
activation by phosphorylation. However, no loss of expression of cell–cell adhesion proteins, including
E-cadherin, ZO-1 and Occludin-1, is observed. Additionally, migration does not lead to cell dispersal but to a
characteristic organized pattern in rows, in turn associated with Golgi compaction, providing strong evidence
of a morphogenic collective migration. Besides migration, HGF increases oval cell invasion through extracellular
matrix, a process that requires PI3K activation and is at least partly mediated by expression and activation of
metalloproteases. Altogether, our ﬁndings provide novel insights into the cellular and molecular mechanisms
mediating the essential role of HGF/c-Met signaling during oval cell-mediated mouse liver regeneration.
© 2015 Elsevier B.V. All rights reserved.1. Introduction
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(hepatocytes and cholangiocytes), thus actively contributing to repopu-
late the liver and restore liver function. This oval cell-mediated regenera-
tive process is often referred to as “oval cell response” or “ductular
reaction”due to the fact that proliferating oval cells organize into ductular
structures or ductules [1]. Their role in regeneration of the damaged liver
has been convincingly proven mostly based on their presence in
advanced stages of human liver diseases, surrounded by immature hepa-
tocytes, which indicates an ongoing regeneration response; and their
demonstrated capacity to repopulate the liver upon transplantation in
animal models of liver injury. Hence, they have been considered as
the second line of defense against liver injury [2]. Unfortunately, the
repopulation process is often not efﬁcient enough and hepatic failure
cannot be always prevented. Strikingly, recent evidences suggest that
a sustained oval cell response may indeed aggravates ﬁbrosis [3].
Furthermore, it is also recognized that deregulation of the oval cell acti-
vation/differentiation pathway can result in malignant transformation
of these cells that subsequently become tumor-initiating cells and
drive hepatocarcinogenesis [4]. It becomes clear that, in spite of their
relevance in liver pathophysiology, our knowledge about the complex
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uncertainties, their plasticity, repopulation capacity and differentiation
potential keep high expectations regarding their use as suitable sources
or targets for clinical application strategies aimed at accelerating or
improving regeneration for the treatment of liver diseases.
The regulation of the oval cell response seems to be as complex as
the response per se. Thus, a combination of genetic studies in rodents
and in vitro studies have allowed to identify a number of cytokines
and growth factors, which are somehow involved in oval cell regulation
[5,6]. Hepatocyte growth factor (HGF) originally identiﬁed as a strong
mitogen for mature hepatocytes, has been demonstrated to be a growth
factor essential not only during liver development [7], but also to
promote a successful regenerative response after acute and chronic
liver damage [8–10]. HGF triggers its biological activities through
binding to a single tyrosine kinase receptor named c-Met. Activation
ofMet by HGF induces a variety of cellular responses, including prolifer-
ation, differentiation, survival, motility and extracellular matrix (ECM)
degradation [11,12]. Interestingly, all these biological activities appear
to be part of a unique c-Met-activated morphogenic response known
as “invasive growth”, which operates during normal development and
regeneration but it also has a malignant counterpart responsible for
cancer progression and metastasis [13].
Previously, we have demonstrated that HGF/c-Met signaling is
essential to promote oval cell survival in vitro via autocrine and paracrine
mechanisms involving PI3K activation [14,15]. Consistent with its impor-
tant regulatory role in oval cell function, in vivo data from c-Met mutant
mouse models have shown that the absence of c-Met results in a failure
of the stem/progenitor cell-mediated regenerative response and
ultimately death from liver failure. Interestingly, loss of c-Met has
more profound effects than just a reduction in oval cell pool, affecting
multiple cellular processes required for regeneration, including oval cell
differentiation and migration [16]. The effects of HGF/c-Met signaling on
the regulation of cell migration are well known. Indeed, HGF was also
identiﬁed as the “scatter factor” due to its capacity to induce disassocia-
tion of cell–cell contacts and increase motility in epithelial cells, resulting
in cell scattering in vitro [17]. On the other hand, HGF also induces
extracellular matrix proteolysis and invasion in various types of non-
tumoral and tumoral cells, including hepatoblasts and hepatocarcinoma
(HCC) cell lines, activities that appear to contribute to both in vivo
liver repopulation capacity and tumor invasiveness and metastasis,
respectively [18,19].
Despite these enlightening observations, the regulation of the
complex migratory process involved in the regenerative response
mediated by oval cells has not been characterized. In this study, we
have investigated the relevance of the HGF/c-Met signaling pathway
on regulation of mouse oval cell migration and invasive properties
and the mechanisms mediating its effects. For that, we have used
an in vitro model of oval cell lines expressing either a functional or
non-functional c-Met receptor lacking tyrosine kinase activity, Metﬂx/ﬂx
and Met−/− oval cells, respectively. We demonstrate that HGF promotes
a migratory and invasive response in oval cells that ultimately leads to
cell rearrangement rather than to cell scatter. Additionally, we have ex-
plored the signaling mechanisms mediating HGF invasive response and
have proved an essential role for PI3K activation and metalloproteases
(MMPs) expression and activation to achieve such response.
2. Material and methods
2.1. Reagents and antibodies
Mouse recombinant HGF was purchased from R&D Systems. ERK
inhibitor UO126, p38 Inhibitor SB203580 and PI3K inhibitor LY294002
were from Calbiochem. The broad spectrum MMP inhibitor marimastat
was kindly supplied by Dr. M. Quintanilla (IIB, Madrid, Spain). Dulbecco's
modiﬁed Eagle'smedium (DMEM), fetal bovine serum (FBS) and trypsin-
EDTAwere obtained fromGibco (Life Technologies). Type IV collagen andmatrigelwere fromBDBioscience. Penicillin, streptomycin,HEPES, bovine
serum albumin (BSA), crystal violet dye, DNA oligos and buffer reagents
were from Sigma-Aldrich. Oligo-dT was from Roche Diagnostics; RNeasy
Kit from Quiagen; SuperScript III RNase H Reverse Transcriptase from
Invitrogen (Life Technologies); ECL reagent and Glutathione Sepharose
4B beads (17-0756) were from GE Healthcare Europe. Vectashield
mounting medium with DAPI was from Vector Laboratories. The
anti-occludin (711500) and anti-ZO-1 (617300) antibodies were
from Invitrogen (Life Technologies). Anti-β-actin (clone AC-15) was
from Sigma-Aldrich. Anti-PI3K p85 (06-195) was from Millipore; anti-
GM130 (610823) from BD Bioscience and anti-beta COP (NB120-2899)
from Novus Biologicals. Anti-phosphotyrosine antibody (4G10, 05-321)
and anti-Rac-1 (clone 23A8, 05-389) were from Millipore.
2.2. Cell lines and culture conditions
Metﬂx/ﬂx and Met−/− oval cell lines were generated as described
previously [14]. Early passage cells (passages 1 to 8) were maintained
in DMEM supplemented with 10% FBS in a humidiﬁed incubator at
37 °C and a 5% CO2 atmosphere. The medium was replaced every
three days and cells passaged at 90% conﬂuency. Prior to stimulation
with growth factor cells were serum starved for 2–12 h. Inhibitors
were added 30 min to 1 h before addition of growth factor.
2.3. Cell scatter assays
Oval cells were allowed to grow as distinct individual colonies by
seeding at low density (3400 cells/cm2) in DMEM supplemented with
10% FBS. Next day, cultured cells were visualized under phase contrast
microscopy and several ﬁelds of view were randomly selected and
marked on the bottom of the plate using a paint marker to be able to
follow up cell behavior for the next 48 h. Then, cells were stimulated
with HGF (40 ng/ml) in DMEM–0% FBS and photographs of the selected
ﬁelds were taken at different time points after treatment (0, 6, 16, 48 h)
under a phase contrast microscope using a 10× objective. Untreated
cells seeded and maintained in the same culture conditions are used
as control.
2.4. In vitro wound healing migration assays
Cells (34000 cells/cm2) were seeded in Falcon 35 mm-cell culture
dishes and grown to conﬂuence in a complete medium. A sterile 10 μl
pipette tip was used to make a wound across a cell culture monolayer.
Cell debris was removed by discarding the medium and washing
three times with PBS. Cells were then incubated in DMEM–0% FBS
supplemented or not with HGF (40 ng/ml). Multiple photographs of
the wound were taken immediately after wounding (0 h) and 48 h
later under a phase-contrast microscopy using NIS-Elements software
(Nikon). The efﬁciency of the wound healing process was determined
by calculating the area of the cell gap at the indicated times (0 and
48 h), using ImageJ software. Three images were used for each wound
at each experimental point and the experiment was always carried
out in triplicates. The results are expressed as percentage of healing at
48 h with respect to zero time.
2.5. Invasion assays
In vitro invasion assays were performed using Transwell inserts
(24-well plate inserts; 8 μm pore size; BD Bioscience) coated either
with reconstituted Matrigel basement membrane (0.3 mg/ml) or type
IV collagen (7.5 μg/ml) according to themanufacturer's recommendation.
15,000 cells were added to the upper chamber and incubated in the
presence or absence of HGF (40 ng/ml) in DMEM–0% FBS. When kinase
inhibitors were used, cells were serum starved for 2 h and pretreated
with the inhibitors for 1 h prior to seeding on chambers. After 24 h in
culture, cells in the upper chamber were carefully removedwith a cotton
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stained with crystal violet 0.2% in 2% ethanol for 20 min. Several
representative photographs of each well were taken. Quantiﬁcation
of the invasion process was done by counting stained invaded cells
in at least 20 ﬁelds/insert using phase-contrast microscopy (Eclipse
TE300, Nikon) and a 10× objective. Each experiment was run in
triplicates to conﬁrm reproducibility of data.
2.6. Quantitative reversed transcriptase-polymerase chain reaction
(qRT-PCR)
Total RNA isolation, reverse transcription and quantitative PCR was
performed as previously described [14,15]. Primer sequences used in
the study are provided in supplementary information (Supplementary
Table 1).
2.7. Immunoﬂuorescence analysis
To analyze protein expression by regular or confocal ﬂuorescence
microscopy, we used standard protocols previously described [14].
F-actin stainingwas performed using rhodamine-conjugated phalloidin
following previous protocols [20]. Here we provide speciﬁc details on
cell preparation, ﬁxation and/or staining for particular antibodies. In
all cases, cells were seeded on 2% gelatin-coated glass coverslips in
DMEM supplemented with 10% FBS. For BetaCOP, GM130 and ZO-1
staining, cells were ﬁxed with 4% paraformaldehyde for 20 min at RT
followed by permeabilization in PBS containing 0.1% Triton X-100–0.1%
BSA for 20 min. After ﬁxation–permeabilization, cells were incubated in
a blocking solution (2% BSA in PBS, 1 h) and then incubated at 37 °C
with primary antibodies (diluted 1:50 in PBS–1% BSA, 1 h). Fluorescent-
conjugated secondary antibodies (anti-mouse Alexa 488 or 594 and
anti-rabbit Alexa 488) were diluted 1:200 in PBS–1% BSA and applied
for 1 h at RT. Cells were prepared for visualization by embedding in
a Vectashield mounting medium with DAPI and visualized in a Leica
TCS-SL confocal microscope with a 63× objective or an Olympus BX-60
ﬂuorescence microscope with a 60× objective.
2.8. Immunoblotting and immunoprecipitation
For total cell lysate preparation, Western blotting and immunopre-
cipitation assays we followed standard protocols described previously
[14]. Speciﬁc details are as follows. Phosphorylated ZO-1 was detected
by immunoprecipitation with an antibody against phosphotyrosine
(4G10, 1 μg/ml) and anti-mouse IgG whole molecule-agarose antibody
followed by Western blot analysis using an anti-ZO1 antibody (diluted
1:1000 in a Tris-buffered saline containing 0.1% Tween 20 (TTBS) and
5% non-fat dried milk). For detection of occludin-1 (OCL-1), E-cadherin
(E-CAD), β-actin (β-ACTIN) and p85 by Western blot the primary
antibodies were diluted 1:500 to 1:2000 in 5% non-fat dried milk
TTBS. Detection was done using horseradish-conjugated secondary
antibodies (diluted 1:3000–1:5000 in 0.5% non-fat dried milk TTBS)
and the enhanced chemiluminescence method.
2.9. Rac-1-GTP pull down assay
Cells were lysed in amagnesium lysis buffer (MLB) pull down buffer
(25 mM Hepes (pH 7.5), 150 mM NaCl, 10 mMMgCl2, 1 mM EDTA, 1%
NP40, 1% Glycerol, 10 μg/ml Leupeptine, 10 μg/ml Aprotinine, 1 mM
NaF and 1 mM NaVO3) and protein concentration was measured by
Bradford assay. A GST-Pak-1 protein bound to glutathione sepharose
beads was used to precipitate Rac-GTP from total cell extracts
(0.5–1 mg of protein), essentially as described [21]. Rac-1 was detected
by Western blotting and densitometric analysis was used to normalize
Rac-GTP levels to total Rac-1 levels.2.10. Small interfering RNA (siRNA) knockdown assays
Transient siRNA knockdown assays were performed as described
previously [15]. PI3K regulatory subunit p85α siRNA SMART pool
consists of four double-stranded siRNAs commercially designed and
tested by Dharmacon (SMARTpool siRNA reagents; Dharmacon) whose
sequences are: ACGCGAAGGCAACGAGAAA, UAAUAAACCACUACCGGAA,
GAAGUCAAGCAUUGCGUCA, CUAAAAUGCACGGCGAUUA. siControl non-
targeting siRNA Pool (Dharmacon) was used as negative control. For
siRNA transfection we used TransITsiQuest reagent (Mirus) according to
the manufacturer's recommendation and a ﬁnal siRNA concentration of
50 nM. After transfection, cells were incubated for 24 h in a complete
medium to allow efﬁcient target down-regulation prior to protein
harvesting or cell replating for invasion assays.
2.11. Statistical analysis
Statistical analysis was performed by Students t-test method. The
differences were assumed signiﬁcant at P b 0.05.
3. Results
3.1. HGF promotes oval cell migration but not cell scattering
Since HGF is known as scatter factor due to its ability to promote cell
scatter on epithelial cells [17], we ﬁrst run scatter assays with Metﬂx/ﬂx
oval cells, which have proved to respond to HGF [14]. Migratory cells
were easily visualized both in untreated and HGF treated cultures, but
interestingly, there was no cell scattering from the colonies. Instead, in
the presence of HGF treatment cells clearly migrated to cluster rather
than to scatter (Fig. 1A). Furthermore, in a second stage of themigratory
process, cell rearrangement was observed within the colonies in such a
way that cells seemed to arrange in rows. This phenomenon was not
seen in untreated cells. In these conditions, however, there was some
cell loss due to cell sensitivity to serum deprivation, as previously
described [14]. This migratory response elicited by HGF was not
observed in Met−/− oval cells (data not shown). To further test the
effect of HGF on oval cell migration we also run in vitro wound healing
assays. As seen in Fig. 1B–C, oval cells intrinsically attempted to migrate
toward the wound but this capacity was clearly increased in the
presence of the growth factor, an effect that was not seen in Met−/−
oval cells, proving its speciﬁcity. Furthermore, consistently with our
initial observations, wound directed oval cell migration appeared to
show a collective rather than a single cell migration mode. Altogether,
our data demonstrates that HGF promotes oval cell migration. However,
it does not act as a scatter factor.
3.2. HGF-triggered migratory response in oval cells is associated with
reorganization of cytoskeleton and cell–cell contacts but not an EMT process
Cell migration implies changes in F-actin cytoskeleton [22]. There-
fore, using standard culture conditions that allow free cell movement,
that is, low cell densities similar to those used for scatter assays, we
analyzed by confocal microscopy the cytoskeletal F-actin pattern in
oval cells after treatment with HGF. HGF-treated mouse oval cells
displayed a highly dynamic and dense actin network. Thus, F-actin-
enriched structures including lamelipodia and ﬁlopodia were seen at
the migratory front of individual migrating cells and cells at the edges
of the colonies (Fig. 1D), indicating a continuous reorganization of
actin cytoskeleton. Accordingly, HGF activated Rac1 (Fig. 1E), one of
the key signaling components controlling actin cytoskeleton organiza-
tion and cell migration [23]. It is worthmentioning that all experiments
were done in the absence of a matrix substrate. However, there is a
critical physical and functional link between actin cytoskeleton and
ECM. Therefore, we analyzedwhether HGFmight induce the expression
of ECM proteins and integrin receptors in oval cells. Indeed, after 24 h of
Fig. 1. Effect of HGF on oval cell migration, F-actin cytoskeleton and Rac1 activity. A. Scatter assays. Metﬂx/ﬂx oval cells were cultured at low density on plastic dishes with or without HGF
treatment (40 ng/ml). Representative phase contrast images of a randomly selected area of the dish are shown. Scale bar = 100 μm. B. Wound healing assays. Metﬂx/ﬂx and Met−/− oval
cells were cultured at conﬂuency on plastic dishes. Next day a wound was done using a sterile tip and cells were cultured during 48 h with or without HGF (40 ng/ml). Phase contrast
images were taken at zero time (after wounding) and 48 h later. Scale bar = 100 μm. C. Quantitative analysis of wound closure after 48 h. Data are expressed as % of closure and are the
mean ± SEM of four independent experiments. **P b 0.01 HGF-treated vs untreated Metﬂx/ﬂx. D. Confocal microscopy images of F-actin staining in Metﬂx/ﬂx oval cells untreated or treated
with HGF (40 ng/ml) for 16 or 24 h. Illustrative lamelipodia and ﬁlopodia structures are indicated by arrowheads and arrows, respectively. Representative images out of 4 experiments are
shown. Scale bar = 45 μm. E. Analysis of Rac-1 activation by pull-down assays in Metﬂx/ﬂx oval cells untreated or treated with HGF (40 ng/ml) for 5 and 10 min. A representative experiment
out of 5 is shown.
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integrin alpha2 and beta2, collagen 1a1, laminin3 and ﬁbronectin1
mRNAs, but no regulatory effect was seen on collagen 3a1, proving the
speciﬁcity of the response (Supplementary Fig. 1).
In parallel, we looked for changes in expression and/or subcellular
localization of cell-to-cell contact proteins.We did not detect any obvious
differences in mRNA or protein levels of E-cadherin, a member of the
cadherin protein family that forms part of the adherens junctions
(Fig. 2A, B). Similarly, ZO-1 and OCCLUDIN-1, two protein components
of tight junctions (TJ), were unaltered by HGF treatment (Fig. 2B). Never-
theless, we analyzed the subcellular localization pattern of E-cadherin by
confocal microscopy to see whether HGF provoked any alteration in the
E-cadherin distribution but we could not identify clear differences in
localization (Supplementary Fig. 2A). When we analyzed ZO-1 localiza-
tion pattern we observed a switch from cell-to-cell contact sites to a
more diffuse intracellular staining pattern (Fig. 2C). Furthermore,
in agreement with previously published data [24], ZO-1 cytoplasmic
relocalization was correlated with activation of the protein by
phosphorylation, as evidenced by immunoprecipitation assays (Fig. 2D).
These results suggest that HGF induces profound changes in cell-to-cell
contacts in oval cells. Importantly, all the described eventswere abolishedinMet−/− oval cells,which demonstrate that they depend on the tyrosine
kinase activity of HGF receptor, c-Met.
Induction of a migratory phenotype is often associated with cell
phenotypic change, more speciﬁcally, with an epithelial–mesenchymal
transition (EMT). This has been also described in HGF-triggered
migration on liver cancer cell lines [25]. Here, we describe that the
pro-migratory activity triggered by HGF in oval cells is accompanied
by changes in F-actin cytoskeleton and subcellular localization of
ZO-1. However, our results do not evidence a switch to a mesenchymal
phenotype nor down-regulation of E-cadherin or cell dissociation, all of
them being typical characteristics of EMT. These observations seemed
to discard a potential induction of an EMT process by HGF in the oval
cell model. Nevertheless, to further demonstrate our hypothesis we
measured Snail mRNA levels, the best known master regulator of EMT
[26]. We could not detect any induction of Snail mRNA expression
upon treatment with HGF (Fig. 2E). It is worth noting that HGF failed
to induce Snail or down-regulate E-cadherin expression regardless of
the absence or presence of matrix as culture substrate (Supplementary
Fig. 2B). We run parallel analysis using wound healing assays, as a
culture condition to push the migratory phenotype of the cells. Results
evidence that wound healing by itself provokes an induction of Snail
Fig. 2. Effect of HGF on cell–cell adhesion proteins expression, ZO-1 subcellular localization and activation. A. qRT-PCR analysis for E-cadherin gene expression inMetﬂx/ﬂx andMet−/− oval
cells cultured for 24 and 48 hwith or without HGF (40 ng/ml). Data represent RQ values and aremean± SEM of 6 experiments. B.Western blot analysis for ZO-1, Occludin-1 (OCL-1) and
E-cadherin (E-CAD) protein levels. Metﬂx/ﬂx andMet−/− oval cellswere cultured for 24 and72hwith orwithoutHGF (40ng/ml). Total protein lysateswere collected andused forWestern
blot analysis. β-Actin was used as loading control. C. Confocal microscopy images of ZO-1 staining in Metﬂx/ﬂx and Met−/−oval cells either untreated or treated with HGF (40 ng/ml) for
24 h. Representative images out of 4 experiments are shown. Scale bar = 20 μm. D. Analysis of ZO-1 activation by immunoprecipitation with anti-phosphotyrosine antibody followed by
immunodetection of ZO-1 with a speciﬁc antibody, in cells cultured for 24 h with or without HGF (40 ng/ml). Total ZO-1 protein levels in the same lysates analyzed byWestern blot are
shown as loading control. A representative experiment out of 4 is shown. E. qRT-PCR analysis for Snail gene expression inMetﬂx/ﬂx and Met−/− oval cells cultured for 24 and 48 h with or
without HGF (40 ng/ml). Data represent RQ values and are mean ± SEM of 6 experiments.
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manner (Supplementary Fig. 3A). However, HGF treatment did not
further induce Snail and interestingly, prevents E-cadherin down-
regulation. Consistently, HGF did not induce loss of expression of
cell junction proteins or changes in E-cadherin staining pattern
(Supplementary Fig. 3B–C). As expected, F-actin cytoskeleton pattern is
consistent with a migratory cell phenotype both in untreated and HGF-
treated, but additionally, under HGF treatment F-actin ﬁbers aligned
along the cells rows are seen, supporting an oriented cell movement
toward the wound (Supplementary Fig. 3C). All these results demon-
strate that even under wound healing conditions HGF-triggered pro-
migratory activity is not associated with EMT or loss of cell-to-cell
contact proteins.
3.3. HGF-triggered migratory response in oval cells is associated with
changes in Golgi organization and polarity
Apart from the absence of cell scattering, one of themost interesting
observations was the cell rearrangement induced by HGF within the
oval cell colonies. This prompted us to hypothesize on a non-randomoriented/polarized migratory response. In an attempt to study such
hypothesis we analyzed the Golgi complex (GC) distribution since it
has been described that polarizedmigratory cells display the GC oriented
toward the direction of migration and this frontward polarization has
been proposed to be involved in directional migration [27]. For that, we
stained GC using an antibody against B-COP, a coat protein of non-
clathrin-coated vesicles of the GC, or an antibody against GM130, a cis-
Golgi matrix protein, and analyzed it by confocal microscopy. As seen in
Fig. 3A, HGF-treated Metﬂx/ﬂx, but not Met−/−, oval cells presented
a tightly packed Golgi structure as evidenced by B-COP staining.
This effect was more prominent after long-term treatment, coinciding
with cell rearrangement. Quantitative analysis demonstrated that HGF
signiﬁcantly increased the percentage of cells showing high Golgi com-
paction (GC occupies less than 1/4th of cell surface), whereas decreased
the number of cells with medium (between 1/4th and 1/2th of cell sur-
face) or none (more than 1/2th of cell surface) Golgi compaction
(Fig. 3B). Identical results were obtained when using anti-GM130 anti-
body (Supplementary Fig. 4). A detailed observation of Golgi position let
us conclude that while in leading cells GC appears to face direction of
migration, cells on rearer positions show a heterogeneous pattern, not
Fig. 3. Effect of HGF on GC subcellular distribution in oval cells. A. Cells were cultured untreated (Control) or treated with HGF (40 ng/ml) for the indicated time periods. Then, they were
ﬁxed and stained with B-COP antibody to visualize GC by confocal microscopy. Representative images out of 3 experiments are shown. Scale bar = 50 μm. B. Quantitative analysis of GC
compaction degree. Cells were divided in three categories depending upon the degree of compaction: High (GC extended around 1/4th of nucleus surface or less), Medium (GC extended
between 1/4th and 1/2th of nucleus surface), None (GC extendedmore than 1/2th of nucleus surface). Data are expressed as % of cells in each category and aremean±SEMof 3 experiments. C.
Confocal microscopy images of ZO-1 (green ﬂuorescence) and GM130 (red ﬂuorescence) staining inMetﬂx/ﬂx cells at 48 h after wounding and treatment with HGF (40 ng/ml). Representative
images out of 2 experiments are shown. Scale bar = 50 μm.
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further clarify this issue, we performed Golgi staining in wound healing
assays, a best characterizedmodel for directed cell movement. Image in
Fig. 3C shows a migrating front toward wound edge in HGF-treated
cells. As seen in standard cultures, GC compaction was very clear
under these conditions. The GC of the cell at the front of the group
was facing the wound whereas the rest of the cells showed a more
heterogeneous positioning pattern with predominance of lateral
position. All these results further demonstrate aHGF-inducedmigratory
response in oval cells and at the same time support a collectivemigration
pattern.
3.4. HGF increases oval cell invasion through extracellular matrix:
involvement of matrix metalloproteinases (MMPs)
Once we had demonstrated that the HGF/Met pathway induces a
complex and speciﬁc migratory response in oval cells, we questioned
whether this signaling pathway could also regulate oval cell invasion
capacity through extracellular matrix substrates. With this aim, we
performed additional experiments using transwells coated either with
collagen IV or matrigel. Results demonstrated a signiﬁcant increase inthe number of cells that migrated and invaded to the bottom side of
the ﬁlters upon HGF treatment as evidenced by the microcopy images
and quantitative analysis (Fig. 4A–C). Once again, no signiﬁcant differ-
ences were observed between untreated and treated Met−/− oval
cells. MMPs are major proteolytic enzymes known to play a central
role during extracellular matrix degradation and remodeling, therefore
being key players in cell invasion [28]. Their expression and activity can
be modulated by growth factors and cytokines. In fact, HGF has been
reported to increase the expression of several members of the MMP
family to mediate tubulogenesis or to increase tumor cell invasiveness
[29–31]. This prompted us to analyze the expression ofMMPs, including
MMPs 2, 3, 7, 9, 10, 11, 13, 14, as well as TIMP1 and 3, two members of
the tissue inhibitors of metalloproteinases (TIMPs), key regulators of
MMPs [32]. As shown in Fig. 4D, we found up-regulation of MMPs 3, 9,
10 and 13mRNAs in oval cells treatedwithHGF, both in normal cultures
(on uncoated plastic dishes) or in cells cultured on matrigel-coated
dishes (data not shown). No signiﬁcant changes were found in the
other MMPs analyzed (data not shown) or in TIMP 1 and 3 (Fig. 4D).
To test whether the MMP matrix degrading activity was important for
oval cell invasion we run invasion assays in the same conditions to
those performed before but in the presence of marimastat, a well-
Fig. 4.Analysis of the effect of HGF on oval cell invasion through extracellularmatrix. Role of MMPs. A–C: Cells were seeded on the upper chamber of transwells coatedwith collagen IV or
matrigel and incubated for 24 h in the absence or presence of HGF (40 ng/ml). Cells that had invaded the bottom chamber were ﬁxed and stained with crystal violet and analyzed bymi-
croscopy. A. Representative phase contrast images of the different culture conditions are shown. Scale bar = 100 μm. B and C. Quantitative analysis of cell invasion. Data are expressed as
number of invaded cells and aremean± SEM of at least 5 experiments performed in duplicates. **P b 0.01 and ***P b 0.001 respect to untreated cells. D. qRT-PCR analysis for MMP3, 9, 10,
13, TIMPs 1 and 3. Metﬂx/ﬂx cells were seeded on uncoated plastic dishes and cultured untreated or treated with HGF (40 ng/ml) for 24 h. Total RNA was isolated and used for qRT-PCR
analysis. Data represent RQ values and aremean±SEMof at least 4 experiments. *Pb 0.05; **P b 0.01 respect to untreated. E. Effect ofMMP inhibition on oval cell invasion. Invasion assays
in the absence or presence of HGF (40 ng/ml) and/ormarimastat (10 μM)were conducted. Data represent number of invaded cells expressed as fold changewith respect to untreated cells
and are mean ± SEM of 2 independent experiments run in duplicate-triplicate. ***P b 0.001.
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inhibitor partly but signiﬁcantly decreased basal and HGF-stimulated
cell invasion (Fig. 4E), strongly suggesting their contribution to cell
invasion.
3.5. PI3K activation is critical for the HGF-induced oval cell migratory/
invasive response in oval cells
Next, we aimed at clarifying the HGF-triggered signaling pathways
mediating the migratory/invasive response elicited by this growth
factor in oval cells. Before, we have reported that HGF through c-Met
activates PI3K/AKT and ERK1/2 MAPK pathways [14] in oval cells. Wehave also demonstrated HGF/c-Met-mediated activation of p38MAPK
in these cells (Supplementary Fig. 5). Furthermore, HGF/c-Met-
triggered signaling is not signiﬁcantly altered when oval cells are
cultured on collagen IV or matrigel (Supplementary Fig. 5). To analyze
the role of these signaling pathways in the HGF pro-invasive activity
we used selective inhibitors, including LY294002 (PI3K inhibitor),
UO126 (ERK1/2 MAPK inhibitor) and SB203580 (p38α/βMAPK inhibi-
tor). Treatment of cells with LY294002 completely abolished HGF-
induced invasive response, both on collagen IV and matrigel (Fig. 5A, B).
SB203580 inhibitor only blocked HGF effect on collagen IV but not
matrigel, evidencing a potentially differential role for this signaling
pathway depending upon the extracellular matrix substrate used.
Fig. 5. Analysis of the signaling pathwaysmediating HGF-induced oval cell invasion. A, B: Quantitative analysis of cell invasion through collagen IV (A) ormatrigel (B) inMetﬂx/ﬂx oval cells
treated in the absence or presence of HGF (40 ng/ml), LY294002 (5 μM), UO126 (5 μM) or SB203580 (10 μM). Data are expressed as fold change with respect to untreated cells and are
mean ± SEM of at least 3 independent experiments. *P b 0.05; **P b 0.01; ***P b 0.001. C. Western blot analysis of the p85 silencing efﬁciency. Metﬂx/ﬂx cells were transfected with p85
speciﬁc siRNAs (50 nM). Next day, cells were treated (H) or not (C) with HGF (40 ng/ml) for 24 h. Total lysates were collected and used for Western blot detection of p85 using a speciﬁc
antibody. β-Actin was used as loading control. The ratios of p85 to β-actin obtained by densitometric analysis are shown and expressed as fold change with respect to control (untreated
cells transfected with non-targeting siRNAs, NT). D,E: Effect of p85 silencing on HGF-induced oval cell invasion. 24 h after transfection with non-targeting siRNAs (NT) or p85 speciﬁc
siRNAs (si p85) cells were trypsinized and seeded on transwell chambers coated with collagen IV (D) or matrigel (E) and cultured for 24 h with or without HGF (40 ng/ml). Data are
expressed as fold change with respect to control and are mean ± SEM of 2 (collagen) or 5 (matrigel) independent experiments run in duplicate–triplicate. *P b 0.05; **P b 0.01. F: Effect
of kinase inhibitors on HGF-induced MMP expression. Metﬂx/ﬂx cells were seeded on uncoated plastic dishes and cultured untreated or treated with HGF (40 ng/ml), LY294002 (5 μM) or
SB203580 (10 μM) for 24 h. Total RNA was isolated and used for qRT-PCR analysis. Data represent RQ values and are mean ± SEM of 2–3 experiments. *P b 0.05; **P b 0.01 respect to
untreated. G: Effect of p85 silencing on HGF-induced MMPs expression. 24 h after transfection with non-targeting siRNAs (NT) or p85 speciﬁc siRNAs (si p85) cells were serum-starved
and treated ornotwithHGF (40 ng/ml) for 24h. Total RNAwas isolated and used for qRT-PCRanalysis. Data represent RQ values and aremean±SEMof 2 experiments. P b 0.05; **P b 0.01;
***P b 0.001.
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either through matrigel or collagen IV. In summary, these results
pointed to a critical role for PI3K during HGF-induced oval cell migra-
tion/invasion. To conﬁrm such a role, we carried out siRNA-mediated
transient silencing experiments using siRNAs speciﬁc for p85, the regula-
tory subunit of PI3K. We reached an average gene-silencing efﬁciency of
70–80%. A Western blot of a representative silencing experiment is
shown (Fig. 5C). As seen in Fig. 5D and E, p85 knockdown blocked
HGF-induced oval cell invasion, thus demonstrating that activation of
PI3K is required for this effect.
Our data evidenced that MMPs contribute to HGF-induced oval cell
invasion. The signaling mechanisms mediating MMP regulation by
HGF remain elusive. Therefore, we ought to analyze whether they are
direct targets for p38 α/βMAPK and/or PI3K, the two signaling kinases
playing a role in HGF pro-invasive activities in these cells. Indeed,
up-regulation of MMPs 9, 10 and 13 mRNAs was partly or totally
inhibited in the presence of p38MAPK and PI3K inhibitors. MMP3
mRNA expression was not regulated by these inhibitors suggesting a
differential regulation by other signaling pathways. Additionally, p85
silencing prevented the HGF-mediated up-regulation of MMP 9 and
10mRNAexpression. Strikingly,MMP13 induction,whichwas inhibited
by LY294002,was not signiﬁcantly affected by p85 silencing (Fig. 5F and
G). Therefore, all these results prove for theﬁrst time thatHGF promotes
expression of someMMPs in oval cells via PI3K and p38MAPK activation.
Hence, HGF acting through PI3K and p38MAPK regulates MMP expres-
sion, which would allow cell invasion.
4. Discussion
Studying the behavior of oval cells in response to regulatory factors
appears more than ever fundamental to fully understand their relevance
in liver pathophysiology, their precise role during regeneration after
severe injury and whether or not they are potentially manipulable to
further stimulate regenerative responses safely. Here, we demonstrate
that HGF through c-Met promotes a complex migratory and invasive
response in oval cells, which we propose that it is part of a morphogenic
program activated in these cells during their expansion in the damaged
liver. We also uncover some of the major c-Met-dependent mechanisms
driving such response.
The motogenic activity induced by HGF in epithelial cells has been
extensively studied and has led to a classical model in which HGF acts
as a scatter factor in a standard bidimensional culture, whereas in tridi-
mensional culture on collagen it promotes the formation of long and
branched tubular structures, where cell–cell junctions are maintained
[33]. Tubulogenesis is believed to reﬂect the morphogenic activity
promoted by the HGF/c-Met pathway that in the case of hepatic cells
is displayed as the formation of cord-like structures that seem to
emulate the normal hepatic plate architecture [34,35]. Different from
this classical response, we do not see scattering in oval cells in response
to HGF. Furthermore, the row-like organized morphology of the oval
cell culture in the presence of HGF could at least partially recapitulate
the migratory process of oval cells into the parenchyma during their
expansion in the damaged liver. However, such structures are observed
in the absence of a matrix substrate, showing a higher plasticity of oval
cells for self-organization into epithelial structures, which is most likely
associated with their progenitor nature. It is also plausible to hypothesize
that induction of the expression of ECM proteins and integrin receptors
may well contribute to the HGF-triggered migratory response observed
in these cells.
Additionally, our data demonstrate that HGF-promoted migratory/
invasive response in oval cells is not associated with EMT. The role of
EMT in the pro-migratory/invasive activities of HGF are not at all clear.
It has been postulated as a key mechanism to allow cells move through
extracellular matrix during the early stages of the invasive growth
program induced by HGF in MDCK cells. However, this EMT process is
at most transient and partial since the cells ultimately remain attachedto each other [36]. Differently, the scatter response induced in liver
tumor cells depends on Snail induction mediated by MAPK activation
[25]. Likewise, a positive feedback loop via HGF contributes to maintain
a mesenchymal phenotype in HCC cells, in turn, favoring invasion and
tumor progression [37]. These observations evidence the capacity of
HGF to induce total and partial EMT but such activities depend very
much on cell type and context. On the other hand, in spite of the lack
of effect on ZO-1 expression and the absence of cell dissociation, our
data demonstrate activation and cytosolic translocation of this protein.
Strikingly, this has been associated with stimulation of cell dissociation
andmigration [24]. However, it has also been demonstrated that chang-
es in ZO-1 localization during HGF-inducedmorphogenesis of polarized
MDCK cells do not imply loss of functional integrity of TJ [38]. Besides,
the speciﬁc pattern of Golgi observed during HGF-induced migration
in oval cells is quite similar to that described during HGF-induced
in vitro morphogenesis of MDCK cells [39]. Putting it all together, we
believe that our observations are consistent with the induction of a
collective-type migration as a key component in the speciﬁc morpho-
genic response elicited by HGF in oval cells. It is worth to mention that
parallel experiments that are being performed in our laboratory using
a wt mouse immortalized neonatal hepatocyte cell line as a model
of differentiated liver epithelial cells have shown a differential pro-
migratory and invasive response to HGF. Although HGF also promotes
migration and invasion through ECM not associated with cell scattering
or EMT, neither ZO-1 translocation nor Golgi compaction or cell
rearrangement are seen (Supplementary Fig. 6). These results evidence
that in spite of many similarities the morphogenic responses to HGF
might indeed differ in hepatic cells at different stages of differentiation.
Nevertheless, further investigation is needed to clarify the cellular and
molecular mechanisms behind these differential responses.
Collective migration has been proved to be important during the
morphogenic responses occurring in tissue development and regenera-
tion but it can also participate in invasive and metastatic processes in
tumors [40]. This type of migration can provide clear advantages for the
regenerative response, such as higher production of pro-regenerative
autocrine factors and proteases to facilitate ECM degradation, or protec-
tion of cells against the attack of inﬂammatory cells inﬁltrated in the
damaged tissue. Regarding ECM degradation, we demonstrate that HGF
induces the expression of several metalloproteases in oval cells. MMP
expression and activation contribute to HGF-mediated scattering,
wound-healing and invasion in normal and tumoral hepatic cells
[29–31]. More importantly, MMP-mediated ECM remodeling is a
fundamental process that control collective cell migration and
invasion during tissue patterning [41], an example of that being
tissue remodeling during liver regeneration [42]. Consistent with
this and the crucial pro-regenerative role of HGF, lack of c-Met
results in aberrant tissue remodeling during stem cell-mediated
liver regeneration, associated with a reduction in MMP9 activity
and oval cell migration into parenchyma [16]. Our data indicate
that MMPs contribute to both basal and HGF-stimulated oval cell
migration/invasion through ECM. Nonetheless, we have to keep in
mind that MMPs do much more than degrade physical barriers. They
are also critical for growth factor activation. Thus, MMP-13 activates
HGF by converting the precursor form into the mature form, which
has been proved to accelerate recovery from experimental liver ﬁbrosis
[43], so future studies will allow us to clarify the net contribution of
MMPs in the oval cell response to HGF.
The analysis of the signaling mechanisms involved in the
pro-migratory/invasive response of HGF in oval cells reveals a crucial
role for PI3K. Given the multifunctional nature of HGF/c-Met signaling
pathway, there has been from the beginning an enormous interest in
elucidating the signals mediating the different biological activities
triggered by HGF/c-Met. Strikingly, PI3K activation, shown to mediate
essential anti-apoptotic signal [15,44] has also been reported to be
critical for cell dissociation [45]. Interestingly, cooperation between
multiple signaling pathways is needed to induce HGF morphogenic
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nea epithelial cell migration [46]. Furthermore, concomitant activation
of Ras/ERKs, PI3K/AKT and Rac1/p38 is necessary to reach maximal
migratory capacity in cortical neurons treated with HGF [47]. Why
p38 appears to only be a major participant in oval cell migration/
invasion through collagen IV is not obvious. We could hypothesize
that it might depend on the MMPs regulated by p38, able to degrade
collagen but not other ECM proteins in oval cells. Indeed, p38 has
been involved in MMP1 induction and collagen degradation by HGF
[48]. However, p38 targets not only collagenases but different
types of MMPs in oval cells. Certainly, the substrate is important to
modulate cellular response. For instance, HGF scattering effect on
MDCK is more efﬁcient on collagen I and ﬁbronectin than on laminin I
[49], which is associated to differences in F-actin cytoskeleton organiza-
tion and formation and turnover of integrin-mediated focal adhesions.
p38 also controls F-actin cytoskeleton rearrangement during PDGF-
induced migration [50]. Clearly, several interesting research avenues
remain open to clarify the precise role played by speciﬁc signals in the
HGF pro-migratory/invasive response in oval cells. Nonetheless, we
provide novel mechanistic insights on how HGF regulates MMPs in
oval cells and demonstrate that HGF induces the expression of speciﬁc
MMPs (MMPs 9, 10, 13) acting through PI3K and p38MAPK. These
and other signaling pathways have been involved in the regulation of
several MMPs by different ligands in other cell types, evidencing a
complex, context and stimulus-dependent regulation [51–54]. This
would explain why we do not see regulation of MMP3 by our
targeted kinases. We do not have a straightforward explanation
for the discrepancy between the effect of PI3K inhibitor and p85
silencing on MMP13 expression. However, a PI3K activity-independent
action of p85 regulatory subunit might be possible, as previously
described in other contexts [55]. Moreover, PI3K can be also activated
in a p85-independent manner [56]. Further investigation is needed to
clarify this issue, but overall we provide the ﬁrst characterization of
the signaling cascades involved in the regulation of MMPs by HGF in
oval cells.
Importantly, the fact that PI3K inhibition completely abolishes
HGF-induced invasive response strongly supports a central role for
this pathway and suggests a functional dependency between PI3K and
p38 for collagen invasion, further supported by the fact that PI3K and
p38 share some MMPs as targets. Given that p38 can be a downstream
effector of Rac1 [57] and Rac1 an effector of PI3K [47] our data would
support a signaling axis HGF/c-Met/PI3K/Rac1/p38/MMPs as a major
mechanism mediating the migratory/invasive response of oval cells
through collagen.
In conclusion, we not only demonstrate the pro-migratory/invasive
activity of HGF on oval cells, but provide solid data on the cellular and
molecular mechanisms mediating such activity. The pro-regenerative
effect of the HGF/c-Met signaling pathway is unquestionable. The
HGF/c-Met-dependent migratory/invasive response described here,
together with its anti-apoptotic activity [14] constitute critical compo-
nents in any morphogenic and regenerative response. Therefore, we
believe that our in vitro observations recapitulate the epithelial
morphogenic program induced by HGF during the liver regenerative
response involving oval cells. We cannot rule out the possibility that
the collective pro-migratory/invasive response promoted by HGF/
c-Met in oval cells might contribute to the pro-ﬁbrotic/pro-tumoral
function of these cells upon disruption of the maturation process and
subsequent malignant conversion. However, this hypothesis becomes
harder to sustain if we take into account the over-demonstrated anti-
ﬁbrogenic and therapeutic action of HGF/c-Met signaling in liver and
the severe detrimental effects seen upon c-Met deletion [58,59]. Future
studies will help us clarify these issues, which can provide a step
forward for the development of new therapeutic approaches to ﬁght
liver chronic diseases.
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.bbamcr.2015.05.017.Transparency Document
The Transparency document associated with this article can be
found in the online version.
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